Life from HIMSS: Cerner and Imprivata Announce Authentication Solution Compliant with DEA Requirements for e-Prescribing of Controlled Substances

John Clark
Mar 05, 2013

It’s been an exciting week in New Orleans for HIMSS, and it got even more exciting with the announcement from Cerner and Imprivata about the availability of two-factor authentication to support the prescriber validation requirements for Electronic Prescribing of Controlled Substances (EPCS) from within Cerner Millennium.

Imprivata’s two-factor authentication is the only solution on the market that supports all authentication modalities allowed by the Drug Enforcement Administration (DEA), including finger biometrics, one-time password tokens and smart cards. The DEA's IFR associated with electronic prescriptions for controlled substances was established in June 2010. It covers security technologies and workflow processes relevant to all software application providers, prescribers, and pharmacies involved in enabling, writing, and filling e-Prescriptions for controlled substances.

Healthcare organizations are adopting EPCS in accordance with the DEA’s IFR in order to:

  • Enhance security over controlled substances
  • Streamline workflows for care providers to enable more time focusing on patient care
  • Fulfill prescriptions for patients more quickly
  • Improve patient safety as errors associated with writing and reading prescriptions are reduced
  • Automate refill authorizations
  • Improve productivity and cost efficiency
  • Ensure important patient information about controlled substances is automatically integrated into the EHR

Cerner Instant Access, embedded with Imprivata OneSign, was an integral factor in Cerner Millennium’s successful completion of the DEA’s rigorous EPCS audit process under the Interim Final Rule (IFR). This enables Cerner clients to electronically transmit prescriptions for drugs that are maintained on the DEA’s list of controlled substances.

What other exciting news did you see come out of HIMSS?